20,000 Xarelto Lawsuits Pending Litigation After Severe Bleeding Complaints

   

Xarelto Lawsuits Allege Blood Clots, Uncontrollable Bleeding, Brain Bleeds, And Other Side Effects After Taking The Xarelto Blood Thinner.

xarelto-lawsuit-side-effects-lawyerXarelto lawsuits continue to await litigation as the number of cases filed reaches over 20,000. The Xarelto complaints, filed in state and federal courts, allege the prescription blood thinner causes ischemic stroke, gastrointestinal bleeding, uncontrollable internal bleeding, blood clots, anemia, and other complications that require patients to undergo transfusions or hospitalization. (In Re: Xarelto Products Liability Litigation— MDL No. 2592) (In Re: Xarelto Litigation, Xarelto Bleeding Lawsuits Case ID 150102349)

Xarelto lawsuits accuse Bayer HealthCare, and Johnson & Johnson’s Janssen Pharmaceuticals Inc., which makes and markets the blood thinner, of concealing their knowledge about Xarelto’s serious and dangerous side effects and failing to provide adequate warning that Xarelto causes an increased risk of adverse bleeding events.

“Men and women who suffered life-threatening bleeding side effects after taking Xarelto continue to ask our attorneys about the legal options available to them,” says Dr. François Blaudeau, founder of Southern Med Law.

Southern Med Law’s Xarelto lawsuit attorneys strongly advocate for men and women who believe they have suffered serious bleeding events after taking Xarelto. If you or a loved one experienced life-threatening bleeding events or other complications allegedly associated with Xarelto, please contact Southern Med Law today at 205-547-5525 to learn more about your legal rights and to arrange for a free, no obligation Xarelto lawsuit review, or visit www.southernmedlaw.com for more information and to fill out a contact form.

Xarelto lawsuits in both state and federal courts have been consolidated for coordinated pretrial proceedings. The Philadelphia Court of Common Pleas houses a mass tort for state court Xarelto lawsuits. Currently, 1,526 lawsuits are listed in the mass tort in Pennsylvania. (In Re: Xarelto Litigation, Xarelto Bleeding Lawsuits Case ID 150102349)

A multidistrict litigation (MDL) for federal Xarelto lawsuits was established in the U.S. District Court, Eastern District of Louisiana. There were 18,561 Xarelto complaints pending in the MDL as of September 15, statistics from the U.S. Judicial Panel on Multidistrict Litigation show.

Xarelto (rivaroxaban) is approved by the U.S. Food and Drug Administration (FDA) to prevent strokes, deep vein thrombosis, pulmonary embolism, and blood clots in patients with atrial fibrillation not caused by a heart valve problem. Xarelto lawsuits claim Xarelto is the second most prescribed drug for treating atrial fibrillation, behind only Coumadin (warfarin), and achieved blockbuster status with approximately $2 billion dollars in sales in 2013.

Xarelto, Eliquis and Pradaxa are new generation blood thinners compared to the older blood thinner, warfarin (Coumadin, Jantoven), which the FDA approved in 1954 to prevent stroke in patients with atrial fibrillation. Manufacturers of the newer blood thinners promote the medications as more convenient for patients to use than warfarin. According to the FDA, warfarin uses vitamin K to reverse the anticoagulation effects of the medication. Pradaxa uses the FDA-approved Praxbind antidote.
However, Xarelto and Eliquis do not have an antidote to reverse their anti-clotting effects.
[fda.gov/Drugs/NewsEvents/ucm405148.htm]
[fda.gov/newsevents/newsroom/pressannouncements/ucm467300.htm]

In one recently filed lawsuit, a Virginia woman said she was prescribed Xarelto in March 2013 to treat pulmonary embolism. In January 2015, the woman suffered serious injuries, including gastrointestinal bleeding, iron deficiency anemia due to chronic blood loss, and respiratory failure, the lawsuit states. As a result, the woman underwent several blood transfusions to treat the anemia allegedly caused by Xarelto, according to the lawsuit. (Case No. 2:17-cv-09017; In Re: Xarelto Products Liability Litigation—MDL No. 2592)

About Southern Med Law And Filing A Xarelto Bleeding Lawsuit

Throughout his career, Dr. Blaudeau has worked hard to develop a strong reputation in healthcare litigation. His first-hand knowledge of medicine has made the Southern Med Law team an aggressive and effective attorney and advocate for those who were harmed due to negligent pharmaceutical companies. If you or a loved one where harmed by Xarelto, please contact Southern Med Law today to learn more about your legal rights. Call today for a free, no obligation Xarelto lawsuit review by filling out our online form, or by calling the office directly at 205-547-5525.

Southern Med Law
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203
Phone: (205) 547-5525
Fax: (205) 547-5526
francois@southernmedlaw.com
Medical Negligence/MedicalDevice/Pharma/Qui Tam
www.southenmedlaw.com

This entry was posted in Southern Med Law | Article. Bookmark the permalink.